Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Available vaccines offer protection against cervical, anal, oral, liver and stomach cancers.
New insights into how the cancer-causing stomach bacterium keeps its shape could point the way for future, more-specialized antibiotics.
Many people with GI cancers are diagnosed only after the disease has spread through the body, so this test could aid in early detection.
November is Stomach Cancer Awareness Month.
A consortium of health providers and researchers hopes to raise public awareness of how exercise can benefit those living with cancer.
People living with HIV are also facing cancer as they age.
Study in China sees an association with several cancer types, especially gastrointestinal malignancies.
The immunotherapy led to an improvement in survival for people with gastric or gastroesophageal junction cancers with a high PD-L1 level.
HIV-positive individuals are also diagnosed with cancer at later stages than those without the virus.
A low dose of platinum-based chemotherapy worked as well as higher doses for elderly and frail people with esophageal and stomach cancer.
Median overall survival was 5.7 months for patients receiving Lonsurf and 3.6 months for those receiving placebo.
Changes include approval of new drug therapies, using existing drugs more effectively and revising protocols to reduce toxic side effects.
Keytruda improved survival in people with favorable tumor biomarkers.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.